Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for acute non-traumatic low back pain in the emergency department
ACTRN12618000487213Phase 2Not yet recruiting
- Sponsor
- Dr Bronwyn Bebee
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in lumbodynia (LBP) comparing Cannabidiol plus standard ED treatment with Placebo plus standard ED treatment (2 arms). Primary endpoint: Pain score at 2 hours. Planned start May 2018; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on ACTRN12618000487213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000487213.